Nalu Medical develops implantable neurostimulation devices for chronic neuropathic pain.
Founded in 2014 and based in Carlsbad, US, Nalu Medical develops minimally invasive, battery-free pulse generators and neurostimulation systems for chronic neuropathic pain, including spinal cord and peripheral nerve stimulation. In March 2024, it raised USD 20 million in Series E funding from B Capital and other returning investors. Boston Scientific Corporation acquired the company in October 2025 from Advent Life Sciences, Aperture Venture Partners, BCapital, Decheng Capital, Endeavour Vision, Gilde Healthcare, Longitude Capital, and MVM Partners for an upfront USD 533 million in cash, with additional payment of approximately USD 600 upon achieving milestones.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in